Form 4 for KLRS Kalaris Therapeutics, Inc.
Accepted 2021-09-20 00:00:00 ET · period of report 2021-04-05 · accession 0000899243-21-036577 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-20 | 2021-04-05+ | KLRS | Melian Agustin | Chief Medical Off | S - Sale | $22.11 | -40.5K | 476.0K | -8% | -$896.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-15 | S | D | 800 | $24.03 | 478,918 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2021-07-02 | S | D | 18,586 | $19.99 | 479,718 | D | — | — | |
| 3 | Common | Common Stock | 2021-04-05 | S | D | 18,212 | $23.89 | 498,304 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-17 | S | D | 2,950 | $24.01 | 475,968 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |